Lexology PRO | Canada, France, Global, etc. | 15 Sep 2023
The OPDA warns AstraZeneca over misleading claims, Italy reclassifies CBD products, and the UK Government defers new rules that will require packaging manufacturers to cover recycling costs – plus other key updates.
Borden Ladner Gervais LLP | Canada | 21 Jul 2022
Health Canada has introduced important amendments to the Natural Health Products Regulations, S.O.R./2003-196. The amendments create new labelling…
Bereskin & Parr LLP | Canada | 27 Apr 2022
The Competition Bureau and the Health and Food Products Branch of Health Canada (HFPB) issued a joint notice in January 2022, announcing their…
Audio
Baker McKenzie | European Union, Mexico, USA | 21 Oct 2020
The Health Pod, Baker McKenzie's industry podcast series, highlights sector-specific issues and trends that affect healthcare and life sciences…
Bereskin & Parr LLP | Canada | 7 Jul 2020
Repurposing existing or abandoned drugs is an attractive route to finding a treatment and cure for COVID-19 quickly. To initiate such efforts, the…
Ropes & Gray LLP | Australia, Brazil, Canada, etc. | 8 Apr 2020
The COVID-19 pandemic has had a major impact on the conduct of clinical trials worldwide. Recognizing this impact, National authorities have issued…
Keller and Heckman LLP | USA | 10 Mar 2020
In a March 9 email to stakeholders, Health Canada’s Food Directorate requested data in regard to food additives in certain food flavouring…
Fasken | Canada | 30 Jan 2020
The World Health Organization (WHO) has declared the 2019 Novel Coronavirus outbreak a public health emergency of international concern. There are…
Smart & Biggar | Canada | 29 Jan 2020
There have been a number of key developments in Canadian life sciences IP and regulatory law over the past 12 months, including significant amendments…
Fasken | Canada | 12 Dec 2019
The cannabis market is currently experiencing some turbulence and uncertainty, but that market and underlying consumer demand is well established. As…